Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 3-DIMENSIONAL PHARMACEUTICALS (DDDP) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (29)	10/4/2001 1:44:18 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 146

Thursday October 4, 7:35 am Eastern Time Press Release SOURCE: 3-Dimensional Pharmaceuticals, Inc. 3-Dimensional Pharmaceuticals Announces Presentation at UBS Warburg Conference EXTON, Pa., Oct. 4 /PRNewswire/ -- 3-Dimensional Pharmaceuticals, Inc. (Nasdaq: DDDP - news) today announced that John Gill, Executive Vice President and Chief Financial Officer, will present at the UBS Warburg Global Life Sciences Conference on Monday, October 8, 2001 at 1:00 p.m. ET, at the Pierre Hotel in New York City. 3DP's presentation will be accessible to the public through conference call facilities listed below. Live (domestic): 1-800-500-0177 Live (international): 1-719-457-2679 Recorded (domestic): 1-800-759-8603 Recorded (international): 1-402-220-8537 The recorded line will be available for up to four weeks after the conference. About the Company 3DP (http://www.3dp.com) is an integrated bio-pharmaceuticals company dedicated to revolutionizing small molecule drug discovery and development. 3DP's proprietary platform, DiscoverWorks®, can be applied to virtually any potential drug target. It produces drug candidates suitable for development faster, with fewer resources and a higher probability of success than using conventional drug discovery methods. 3DP is developing its own drug pipeline and collaborates with other pharmaceutical companies in discovery and development. SOURCE: 3-Dimensional Pharmaceuticals, Inc.